Davies DA, Adlimoghaddam A, Albensi BC (2021) Role of Nrf2 in synaptic plasticity and memory in Alzheimers disease
doi:10.1016/j.molmet.2018.07.013 Chumpitazi BP, Kearns GL, Shulman RJ
The drug, clinically known as GLP-1 receptor agonists (GLP-1RA), has been found to provide a novel approach in protecting patients' brains after a stroke, potentially improving neurological recovery
The market is anticipated to experience an annual growth rate of 14.30% (CAGR 2025-2034) This growth is fueled by a rising demand for effective medications, the imperative to manage diabetes and obesity, ongoing clinical trials, and increased research focused on developing long-term, single-dose formulations
Furthermore, multiple subgroup analyses increase the risk of type 1 error
What we still do not know Honesty about the gaps is the difference between reporting and fear-mongering, so here are the things this story does not yet know, stated plainly